WideTrial is a third-party sponsor of group-level Expanded Access programs (EAPs).
WideTrial has raised $22.0M in total funding. The most recent round was Grant. The last funding was announced in November 2024.
WideTrial's investors include National Institute of Neurological Disorders and Stroke.
WideTrial is headquartered in South San Francisco, United States.
WideTrial is a third-party sponsor of group-level Expanded Access programs (EAPs).
WideTrial is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"WideTrial — Funding & Investors." VCBacked, November 19, 2024, https://www.vcbacked.co/company/widetrial. Accessed September 30, 2026.
VCBacked. (2024). WideTrial — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/widetrial
{{cite web |title=WideTrial — Funding & Investors |url=https://www.vcbacked.co/company/widetrial |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated